Justin Belsky

Dr. Justin Belsky is an Assistant Professor of Emergency Medicine at Yale School of Medicine, serving as the COVID-19 Safety Officer and Co-Director of Resident Research in Emergency Medicine. He holds an MD from Wayne State University School of Medicine (2011) and an MPH from Harvard School of Public Health (2016). His research focuses on sepsis diagnosis and treatment, including biomarkers, clinical trials, and risk stratification tools. He led the Yale site for the VICTAS trial evaluating vitamin C, thiamine, and hydrocortisone in septic shock. Dr. Belsky directs the Yale Emergency Medicine Specimen Biobank, collecting samples from critically ill patients for future research. His awards include the Partners in Excellence Team Award (2016) and an Outstanding Poster Award (2015). He is actively involved in resident research training and clinical guideline adherence studies.

Education:

• MD: Wayne State University School of Medicine (2011)
• Emergency Medicine Residency: Henry Ford Hospital (2014)
• Research Fellowship: Massachusetts General Hospital (2016)
• MPH: Harvard School of Public Health (2016)

Research Interests:

• Early sepsis identification and treatment
• Biomarker development for critical illness
• Fluid management strategies in septic shock
• Micronutrient therapies in sepsis
• Emergency department quality improvement

Recent Work Focus:

• Fluid resuscitation protocols and guideline adherence
• Long-term outcomes of sepsis therapies
• Actin cytoskeleton as a sepsis biomarker
• Antibiotic timing in sepsis

Awards:

• 2016: Sepsis Care Redesign, Partners in Excellence Team Award
• 2015: Outstanding Poster Award (Shock Symposium)

Grants & Mentorship:

• Principal investigator for CLOVERS trial (fluid management in sepsis)
• Co-Director of Yale’s Emergency Medicine Research Training Program
• Leadership in resident research mentorship and biobank initiatives